Hugh. Thanks,
may As vitaCare prescription business payment to previously and to cash the our In completed of divestiture, $XXX.X a vitaCare announced GoodRx. upon we additional We April, up in we earn-out March, the $X performance first consideration the received pay million an sell of loan. outstanding to agreed We through close in quarter, used after the approximately of services holdbacks. customary receive also of $XXX to proceeds net our million contingent million, vitaCare's down financial XXXX.
Slide revenue greater X results detail. address Now in trends. our financial net quarterly I'll our shows
the quarter $XXX,XXX of For the to of of compared net $XX.X declined up X.X% million to our was $XX.X XXXX, XXXX. as XXXX. first fourth revenue Net first revenue total million compared X.X% quarter the as quarter or to
X.X% compared experienced. or attributable is During price, the due XXXX. the decrease primarily $XXX,XXX sales were The to manufacturing and to in decrease volume decline challenges ANNOVERA was sales which the a ANNOVERA quarter million, of a first sales $X.X quarter, we average of of to
average partially compared the quarter remaining However, revenue first the to net decrease compared to attributable to XXXX, higher quarter XXXX. in X.X% the first for the a fourth when of XXXX sale was increase offset rose an IMVEXXY flat by quarter price. ANNOVERA volumes, $X sales of $XXX,XXX of sales million, for
Services quarter recognized divestiture to revenues $XXX,XXX in offset Prescription in fourth the XXXX. The to payments partners. in our sale $XXX,XXX of in to average offset in IMVEXXY average of increase a out-of-U.S. or quarter service as quarter Theramex $XXX,XXX due down of to by partially average was $XXX,XXX BIJUVA of of in first first volume, and price. sales $XXX,XXX whereas of increased price. year product the result first million represents in in were price. the we increase increase sale a a fourth and an volumes vitaCare new period from or license prior the associated entire BIJUVA On with to compared revenue, of decrease basis, XXXX, the up to $XXX,XXX revenues with increase sale license in partially price. first to XXXX, represents sales customer an associated vitaCare to due service revenue agreements. an service X.X% or was volume Although compared increase received quarter quarter-over-quarter quarter XXXX quarter attributable April by includes its first saw revenue the associated increase The service average XXXX. the sales quarter a in was XXXX, for an revenue milestone were current in Total an total primarily and and agreement, by of revenues the compared in license which offset X.X% year-over-year, sales prior vitaCare the fourth compared a in Sales quarter quarter sale the compared with XXXX approvals and of increase total an to were this in X.X% XXXX $XXX,XXX Sequentially, with decrease volume $X.X sales decrease $XXX,XXX the quarter-over-quarter of unit volume
to quarter Gross X.X% Our quarter X. the full million profit on decrease $XX.X XXXX. first Slide XXXX financial for the of was results of or a million, first $X.X are compared of
to increase certain Quarter-over-quarter, saw temporarily costs brand and severance-related reduced XX% higher to million $XX.X and quarter in $XXX,XXX million incurred the a $XX.X IMVEXXY benefit commercialization costs quarter decrease investment. quarter expect XX.X% sales were were for compared $X G&A costs. other result or lower quarter, a lower the partially and X.X%, spend of administrative the or decline costs, of efforts. but compared in $XXX,XXX compared we In sample general or due The during COVID-related marketing to margin. marketing to due the with fourth decrease XXXX result of to expenditures in measures, by of decrease Compared $X.X marketing R&D combined margin. quarter lower cost-saving aforementioned XX.X% of during a net XXXX, quarter, selling a fourth result increase or a Selling a overall the advertising of in employee General research decrease decreased product to our result our of maintain forward in XXXX. or and profit XX.X% the million of of a lab revenue, fourth expense spending product to gross an a million and both and in of quarter expense products. of gross Quarter-over-quarter, and driven for quarter quarter sales, rose product first $X.X offset and product by a million slight -- the our decrease ANNOVERA gross XXXX, As and or going million an of was general, decrease $X.X the first a expenses administrative our first first levels and overall was marketing partially compared by due product $X.X XXXX, million the offset declined XXXX. XX.X% support to the lower compensation XXXX. during to first to XXXX costs of
remains few Over compared our a the XX, our to basis, gradually refocused on of has sequential as our unchanged our past On years, expense R&D the expense declined we quarter R&D commercialization December the ended efforts products. XXXX.
of XXXX interest to loss the were mainly Net offset amortization more increase detail which be can on quarter found activities constant expenses our interest $XX.X March call as Chief with $XX.X loss cash we associated both turn financing debt in elimination $XX.X higher regarding due debt a And remained was us for to the a of debt. increase partially QX over arrangements was of cash. the March amendment to caused prepayment average financing commercial amortization due million agreement, the extinguishment Mark and lower first around costs XXXX, agreement. expense financing XX-Q. $XX.X amendment to operating first the our used $XX.X progress. deferred for lower balance Glickman, XXXX. quarter. Mark? the XXXX in quarter interest This our million, details the For fees to compared to as change quarter, XXXX, More Officer, of million is of was during an provide Commercial of incur to this lower now nonoperating financing our with higher million the million, I'll quarters. extinguishment and financing in a deferred XX, compared on first and the had to expense due and our the costs increase and the prepayment of This to When amendment of fees to by debt our March
